受强制性开放获取政策约束的文章 - Shweta Joshi了解详情
无法在其他位置公开访问的文章：4 篇
Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma
S Joshi, AR Singh, DL Durden
Cancer chemotherapy and pharmacology 75, 595-608, 2015
强制性开放获取政策： US National Institutes of Health
Purification and characterization of phosphoenolpyruvate carboxykinase from Raillietina echinobothrida, a cestode parasite of the domestic fowl
B Das, V Tandon, JK Saxena, S Joshi, AR Singh
Parasitology 140 (1), 136-146, 2013
强制性开放获取政策： Department of Science & Technology, India
Atomistic Simulation Studies of the Mechanical and Thermal Properties of Silver Nanowires as Interconnects for Nanoelectronics Applications
SK Joshi, DP Singh, S Dubey
Intelligent Communication, Control and Devices: Proceedings of ICICCD 2020 …, 2021
强制性开放获取政策： Department of Science & Technology, India
DEVELOPMENT AND QUALITY EVALUATION OF LOW GLYCEMIC INDEX BARNYARD MILLET INSTANT Pulav.
S Joshi, S Srivastava
Agricultural Research Journal 55 (3), 2018
强制性开放获取政策： Department of Science & Technology, India
可在其他位置公开访问的文章：38 篇
Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo
S Joshi, AR Singh, M Zulcic, L Bao, K Messer, T Ideker, J Dutkowski, ...
PloS one 9 (4), e95893, 2014
强制性开放获取政策： US National Institutes of Health
A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis
S Joshi, AR Singh, M Zulcic, DL Durden
Molecular Cancer Research 12 (10), 1520-1531, 2014
强制性开放获取政策： US National Institutes of Health
Dual-activity PI3K–BRD4 inhibitor for the orthogonal inhibition of MYC to block tumor growth and metastasis
FH Andrews, AR Singh, S Joshi, CA Smith, GA Morales, JR Garlich, ...
Proceedings of the National Academy of Sciences 114 (7), E1072-E1080, 2017
强制性开放获取政策： US National Institutes of Health, American Heart Association
Combinatorial approach to improve cancer immunotherapy: rational drug design strategy to simultaneously hit multiple targets to kill tumor cells and to activate the immune system
S Joshi, DL Durden
Journal of oncology 2019 (1), 5245034, 2019
强制性开放获取政策： US National Institutes of Health
Vascular remodeling underlies rebleeding in hemophilic arthropathy
V Bhat, M Olmer, S Joshi, DL Durden, TJ Cramer, RFW Barnes, ST Ball, ...
American journal of hematology 90 (11), 1027-1035, 2015
强制性开放获取政策： US National Institutes of Health
MDM2 regulates hypoxic hypoxia-inducible factor 1α stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner
S Joshi, AR Singh, DL Durden
Journal of Biological Chemistry 289 (33), 22785-22797, 2014
强制性开放获取政策： US National Institutes of Health
Targeting the tumor microenvironment in neuroblastoma: recent advances and future directions
S Joshi
Cancers 12 (8), 2057, 2020
强制性开放获取政策： US National Institutes of Health
Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication
GR Campbell, RS Bruckman, SD Herns, S Joshi, DL Durden, SA Spector
Journal of Biological Chemistry 293 (16), 5808-5820, 2018
强制性开放获取政策： US National Institutes of Health
Single agent and synergistic activity of the “first-in-class” dual PI3K/BRD4 inhibitor SF1126 with sorafenib in hepatocellular carcinoma
AR Singh, S Joshi, AM Burgoyne, JK Sicklick, S Ikeda, Y Kono, JR Garlich, ...
Molecular cancer therapeutics 15 (11), 2553-2562, 2016
强制性开放获取政策： US National Institutes of Health
“Re-educating” tumor associated macrophages as a novel immunotherapy strategy for neuroblastoma
KX Liu, S Joshi
Frontiers in immunology 11, 1947, 2020
强制性开放获取政策： US National Institutes of Health
Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors
LLR Hartman, JR Crawford, MT Makale, M Milburn, S Joshi, AM Salazar, ...
Journal of pediatric hematology/oncology 36 (6), 451-457, 2014
强制性开放获取政策： US National Institutes of Health
Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
S Joshi, A Sharabi
Pharmacology & therapeutics 235, 108114, 2022
强制性开放获取政策： US National Institutes of Health
SF2523: Dual PI3K/BRD4 inhibitor blocks tumor immunosuppression and promotes adaptive immune responses in cancer
S Joshi, AR Singh, KX Liu, TV Pham, M Zulcic, D Skola, HB Chun, ...
Molecular cancer therapeutics 18 (6), 1036-1044, 2019
强制性开放获取政策： US National Institutes of Health
Vascular permeability and remodelling coincide with inflammatory and reparative processes after joint bleeding in factor VIII-deficient mice
EJ Cooke, JY Zhou, T Wyseure, S Joshi, V Bhat, DL Durden, LO Mosnier, ...
Thrombosis and haemostasis 118 (06), 1036-1047, 2018
强制性开放获取政策： US National Institutes of Health, American Heart Association
Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype
S Joshi, AR Singh, SS Wong, M Zulcic, M Jiang, A Pardo, M Selman, ...
PloS one 12 (8), e0182851, 2017
强制性开放获取政策： US National Institutes of Health
PI-3K inhibitors preferentially target CD15+ cancer stem cell population in SHH driven medulloblastoma
AR Singh, S Joshi, M Zulcic, M Alcaraz, JR Garlich, GA Morales, YJ Cho, ...
PloS one 11 (3), e0150836, 2016
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定